Cheng-Chun Wu
Overview
Explore the profile of Cheng-Chun Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chuang P, Chang K, Chang C, Chen T, Wu Y, Lin H, et al.
Int J Mol Sci
. 2025 Feb;
26(4).
PMID: 40004112
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, characterized by high incidence and poor survival rates. Glycosylation, a fundamental post-translational modification, influences protein stability, signaling, and tumor...
2.
Lin H, Lee Y, Chang C, Kuo C, Ho H, Wu C, et al.
Ann Med
. 2025 Jan;
57(1):2447405.
PMID: 39829258
Background: Nurses on the frontlines of the pandemic have increased workloads, burnout, and virus exposure, leading to mental health challenges and a lack of resources for patient care. Mental health...
3.
Wu C, Lee Y, Tsai J, Su Y, Ho Y, Chu T, et al.
Biologics
. 2024 Dec;
18:363-375.
PMID: 39649074
Background And Objectives: Stem cell therapy shows great promise for treating Alzheimer's disease (AD). Cholinesterase inhibitors (ChEIs) like donepezil are well-established for alleviating AD symptoms. This study aimed to determine...
4.
Liu C, Ho Y, Lee W, Huang C, Lee Y, Hsieh C, et al.
Environ Toxicol
. 2024 Jun;
39(11):4844-4858.
PMID: 38884142
Environmental antineoplastics such as sorafenib may pose a risk to humans through water recycling, and the increased risk of cardiotoxicity is a clinical issue in sorafenib users. Thus, developing strategies...
5.
Wang H, Su Y, Ho Y, Lee Y, Chu T, Chen K, et al.
J Inflamm Res
. 2023 Sep;
16:4103-4116.
PMID: 37745794
Background: Stroke is a common cause of disability and mortality worldwide; however, effective therapy remains limited. In stroke pathogenesis, ischemia/reperfusion injury triggers gliosis and neuroinflammation that further activates matrix metalloproteinases...
6.
Lee M, Peng W, Wu C, Kan H, Wang D, Teng Y, et al.
Mol Neurobiol
. 2023 Jun;
60(10):5708-5724.
PMID: 37338803
Chronic pain conditions within clinical populations are correlated with a high incidence of depression, and researchers have reported their high rate of comorbidity. Clinically, chronic pain worsens the prevalence of...
7.
Shih P, Chen H, Hsu C, Lin C, Ko C, Hsueh C, et al.
Environ Pollut
. 2023 Mar;
327:121476.
PMID: 36997141
Plasticizers are considered as environmental pollution released from medical devices and increased potential oncogenic risks in clinical therapy. Our previous studies have shown that long-term exposure to di-ethylhexyl phthalate (DEHP)/mono-ethylhexyl...
8.
Su Y, Chen J, Lan K, Lee Y, Chu T, Ho Y, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979886
The clinical use of mifepristone for medical abortions has been established in 1987 in France and since 2000 in the United States. Mifepristone has a limited medical period that lasts...
9.
Tsai Y, Lin C, Yen Y, Wu C, Carvajal C, Molte N, et al.
Front Surg
. 2023 Mar;
10:970681.
PMID: 36936658
Many studies on the recurrence of pressure ulcers after surgical reconstruction have focused on surgical techniques and socioeconomic factors. Herein, we aimed to identify the risk factors of the associated...
10.
Huang S, Huang C, Ko C, Huang C, Liu C, Lee Y, et al.
Gene
. 2023 Mar;
865:147331.
PMID: 36871674
Slow skeletal muscle troponin T (TNNT1) as a poor prognostic indicator is upregulated in colon and breast cancers. However, the role of TNNT1 in the disease prognosis and biological functions...